MannKind | MNKD - Market Capitalization


MannKind reported $1.09B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Insmed USD 23.11B 12.19B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 184M 82M Mar/2026
MannKind USD 1.32B 559M Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Xencor USD 1.19B 301M Jun/2026